- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Proinsulin-to-C-peptide ratio may help identify individuals at highest risk of type 2 diabetes: Study
UK: A recent study published in Diabetes Care has revealed the usefulness of the proinsulin-C-peptide (PI-to-CP) ratio for identifying African American individuals at the greatest risk for β-cell dysfunction and ultimately type 2 diabetes (T2D).
African-American adults tend to have higher acute insulin response to glucose, lower insulin sensitivity, and lower hepatic insulin clearance. Catharine A. Couch, Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, and colleagues conducted the study to test the hypothesis that the proinsulin–to–C-peptide ratio, as an index of proinsulin secretion, would be higher and associated with indices of β-cell function in African American people relative to European-American adults without type 2 diabetes.
For this purpose, 114 African-American and European-American adult women and men were included. A 2-h oral glucose tolerance test was conducted to measure insulin, glucose, proinsulin, and C-peptide and derive indices of β-ce9ll response to glucose.
The Matsuda index was calculated as an insulin sensitivity measure. The disposition index (DI) was calculated for each phase of β-cell responsivity. DI is the product of insulin sensitivity and β-cell response. Pearson correlations were used to determine the relationship of the PI-to-CP ratio with each β-cell response phase (basal, Φb; dynamic, Φd; static, Φs; total, Φtot), insulin sensitivity, and disposition indices (DId, DIs, DItot). Multiple linear regression analysis was used to evaluate independent contributions of BMI, race, and glucose tolerance status on PI-to-CP levels before and after adjustment for insulin sensitivity.
The study led to the following findings:
- African American participants had higher fasting and 2-h PI-to-CP ratios.
- The fasting PI-to-CP ratio was positively associated with Φb, and the fasting PI-to-CP ratio and 2-h PI-to-CP ratio were inversely associated with DId and insulin sensitivity only in African-American participants.
"The findings reveal that the proinsulin-to–C-peptide ratio could be helpful in the early identification of β-cell dysfunction in African American individuals," the researchers concluded.
Reference:
Catharine A. Couch, Francesca Piccinini, Lauren A. Fowler, W. Timothy Garvey, Barbara A. Gower; Proinsulin–to–C-Peptide Ratio as a Marker of β-Cell Function in African American and European American Adults. Diabetes Care 1 December 2023; 46 (12): 2129–2136. https://doi.org/10.2337/dc22-1763
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751